Close Menu
Advertisement
Subscribe
Acute Lymphoblastic Leukemia

RECOURSE trial compared to CORRECT and CONCUR evaluating regorafenib in mCRC

adminBy No Comments1 Min Read

Axel Grothey, MD of Mayo Clinic discusses the RECOURSE trial compared to CORRECT and CONCUR evaluating regorafenib in mCRC at ASCO GI 2016

Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content
Share.

Related Posts

Above Footer
Above Footer
Above Footer